Ranbaxy news

Ranbaxy Laboratories Limited (India) News

Ranbaxy recalls acne drug from US market

Ranbaxy recalls acne drug from US market

Livemint - 19 minutes ago
New Delhi: Drug maker Ranbaxy Laboratories Ltd is withdrawing a single batch of a version of Roche Holding AG's Accutane acne medicine from the US market for the second time this year. Gurgaon ...

US nod for a generic drug lifts Ranbaxy Laboratories

US nod for a generic drug lifts Ranbaxy Laboratories

India Infoline.com - 1 hour ago
On BSE, 2.22 lakh shares were traded in the counter as against an average daily volume of 5.31 lakh shares in the past one quarter. The stock had hit a high of Rs 421.80 and a low of Rs 412 so far ...

Ranbaxy Voluntarily Recalls One Lot Of Sotret Drug In US

Ranbaxy Voluntarily Recalls One Lot Of Sotret Drug In US

Wall Street Journal - 9 minutes ago
BANGALORE (Dow Jones)--India's Ranbaxy Laboratories Ltd. (500359.BY) Friday said it has voluntarily recalled one lot of Sotret Isotretinoin of 40 milligram strength from the US market. "This is a ...

Science scholar award for Gaurav Vadnerkar

Science scholar award for Gaurav Vadnerkar

Times of India - 34 minutes ago
The Ranbaxy Science Scholar 2009 award for Pharmaceutical Sciences has been conferred upon Gaurav Vadnerkar, a National Doctoral Fellow of AICTE and research scholar at the Department of ...

Ranbaxy gains WHO pre-qualification for Indinavir - 400mg ARV capsules

Ranbaxy gains WHO pre-qualification for Indinavir - 400mg ARV capsules

Equity Bulls - 54 minutes ago
Ranbaxy Laboratories Ltd (Ranbaxy) announced today that the World Health Organisation, Geneva (WHO), has included the Company's Indinavir (as sulfate) - 400mg Anti Retroviral (ARV) Capsule, in its ...

Ranbaxy strengthens on WHO approval for AIDS drug

Ranbaxy strengthens on WHO approval for AIDS drug

India Infoline.com - 1 hour ago
On BSE, 4,882 shares were traded in the counter as against an average daily volume of 5.53 lakh shares in the past one quarter. The stock hit a high of Rs 416.90 and a low of Rs 411 so far during ...

Zee, Ambuja Cements, ACC, Maytas, Ranbaxy: India Stock Preview

Zee, Ambuja Cements, ACC, Maytas, Ranbaxy: India Stock Preview

Bloomberg - 2 hours ago
By Anil Varma and Rajhkumar K Shaaw Nov. 13 (Bloomberg) -- The following companies may have unusual price changes in India trading. Stock symbols are in parentheses and share prices are from the ...

Syndicate content